Penny Stock Millionaire

[fast.money]

Business Summary ~ $TPIV

TapImmune Inc., a biotechnology company, engages in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. Its products include TAP cancer vaccine, which is under preclinical toxicology study for the treatment of breast cancer, prostate cancer, lung cancer, liver cancer, melanoma, renal cancer, and colorectal cancer. The company has strategic relationships with Mayo Foundation for Medical Education and Research, and Crucell Holland B.V. TapImmune Inc. was founded in 1999 and is based in Seattle, Washington.